81 related articles for article (PubMed ID: 19897010)
1. Lipid content and response to insulin are not invariably linked in human muscle cells.
Aguer C; Mercier J; Kitzmann M
Mol Cell Endocrinol; 2010 Feb; 315(1-2):225-32. PubMed ID: 19897010
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid.
Sabin MA; Stewart CE; Crowne EC; Turner SJ; Hunt LP; Welsh GI; Grohmann MJ; Holly JM; Shield JP
J Cell Physiol; 2007 Apr; 211(1):244-52. PubMed ID: 17219404
[TBL] [Abstract][Full Text] [Related]
3. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
Gaster M
Biochem Biophys Res Commun; 2009 May; 382(4):766-70. PubMed ID: 19324004
[TBL] [Abstract][Full Text] [Related]
4. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes.
Hansen L; Gaster M; Oakeley EJ; Brusgaard K; Damsgaard Nielsen EM; Beck-Nielsen H; Pedersen O; Hemmings BA
Biochem Biophys Res Commun; 2004 Oct; 323(2):685-95. PubMed ID: 15369805
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle cells from insulin-resistant (non-diabetic) individuals are susceptible to insulin desensitization by palmitate.
Kausch C; Staiger H; Staiger K; Krützfeldt J; Matthaei S; Häring HU; Stumvoll M
Horm Metab Res; 2003 Oct; 35(10):570-6. PubMed ID: 14605989
[TBL] [Abstract][Full Text] [Related]
7. Globular adiponectin stimulates glucose transport in type 2 diabetic muscle.
Kuoppamaa H; Skrobuk P; Sihvo M; Hiukka A; Chibalin AV; Zierath JR; Koistinen HA
Diabetes Metab Res Rev; 2008 Oct; 24(7):554-62. PubMed ID: 18615850
[TBL] [Abstract][Full Text] [Related]
8. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
[TBL] [Abstract][Full Text] [Related]
9. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
[TBL] [Abstract][Full Text] [Related]
10. Storing up trouble: does accumulation of intramyocellular triglyceride protect skeletal muscle from insulin resistance?
Watt MJ
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):5-11. PubMed ID: 18986321
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes mellitus and skeletal muscle metabolic function.
Phielix E; Mensink M
Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance.
Turpin SM; Lancaster GI; Darby I; Febbraio MA; Watt MJ
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1341-50. PubMed ID: 16849630
[TBL] [Abstract][Full Text] [Related]
13. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
14. Lipid metabolism in human skeletal muscle cells: effects of palmitate and chronic hyperglycaemia.
Aas V; Rokling-Andersen M; Wensaas AJ; Thoresen GH; Kase ET; Rustan AC
Acta Physiol Scand; 2005 Jan; 183(1):31-41. PubMed ID: 15654918
[TBL] [Abstract][Full Text] [Related]
15. Myotubes from severely obese type 2 diabetic subjects accumulate less lipids and show higher lipolytic rate than myotubes from severely obese non-diabetic subjects.
Bakke SS; Feng YZ; Nikolić N; Kase ET; Moro C; Stensrud C; Damlien L; Ludahl MO; Sandbu R; Solheim BM; Rustan AC; Hjelmesæth J; Thoresen GH; Aas V
PLoS One; 2015; 10(3):e0119556. PubMed ID: 25790476
[TBL] [Abstract][Full Text] [Related]
16. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells.
JeBailey L; Wanono O; Niu W; Roessler J; Rudich A; Klip A
Diabetes; 2007 Feb; 56(2):394-403. PubMed ID: 17259384
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Wu Y; Ouyang JP; Zhou YF; Wu K; Zhao DH; Wen CY
Sheng Li Xue Bao; 2004 Aug; 56(4):539-49. PubMed ID: 15322693
[TBL] [Abstract][Full Text] [Related]
18. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells.
Hirabara SM; Curi R; Maechler P
J Cell Physiol; 2010 Jan; 222(1):187-94. PubMed ID: 19780047
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel openers prevent palmitate-induced insulin resistance in C2C12 myotubes.
Dymkowska D; Drabarek B; Jakubczyk J; Wojciechowska S; Zabłocki K
Arch Biochem Biophys; 2014 Jan; 541():47-52. PubMed ID: 24262853
[TBL] [Abstract][Full Text] [Related]
20. [In-vivo 1H-MR spectroscopy: the determination of the intra- and extramyocellular lipid content depending on the insulin effect in the direct offspring of type-2 diabetics].
Brechtel K; Machann J; Jacob S; Strempfer A; Schick F; Häring HU; Claussen CD
Rofo; 1999 Aug; 171(2):113-20. PubMed ID: 10506884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
